Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
169.99
-5.44 (-3.10%)
Jan 14, 2025, 4:00 PM EST - Market closed
Inspire Medical Systems Revenue
Inspire Medical Systems had revenue of $203.19M in the quarter ending September 30, 2024, with 32.54% growth. This brings the company's revenue in the last twelve months to $755.59M, up 32.52% year-over-year. In the year 2023, Inspire Medical Systems had annual revenue of $624.80M with 53.19% growth.
Revenue (ttm)
$755.59M
Revenue Growth
+32.52%
P/S Ratio
6.68
Revenue / Employee
$747,373
Employees
1,011
Market Cap
5.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 624.80M | 216.94M | 53.19% |
Dec 31, 2022 | 407.86M | 174.46M | 74.75% |
Dec 31, 2021 | 233.39M | 118.01M | 102.28% |
Dec 31, 2020 | 115.38M | 33.33M | 40.62% |
Dec 31, 2019 | 82.05M | 31.46M | 62.18% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 393.90B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
INSP News
- 1 day ago - Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance - GlobeNewsWire
- 15 days ago - Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 22 days ago - Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound - Investopedia
- 5 weeks ago - Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors - Business Wire
- 7 weeks ago - Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade - Benzinga
- 2 months ago - UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 2 months ago - Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program - GlobeNewsWire
- 2 months ago - Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference - GlobeNewsWire